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Background: The genus Pseudomonas includes a heterogeneous set of microorganisms that can be isolated from
many different niches and nearly 100 different strains have been described. The best characterized bacterium is
Pseudomonas aeruginosa which is the primary agent of opportunistic infection in humans, causing both acute and
chronic infections. Other species like fluorescens, putida or mosselii have been sporadically isolated from hospitalized
patients but their association with the pathology often remains unclear.
Results: This study focuses on the cytotoxicity and inflammatory potential of two strains of Pseudomonas mosselii
(ATCC BAA-99 and MFY161) that were recently isolated from clinical samples of hospitalized patients. The behavior
of these bacteria was compared to that of the well-known opportunistic pathogen P. aeruginosa PAO1. We found
that P. mosselii ATCC BAA-99 and MFY161 are cytotoxic towards Caco-2/TC7 cells, have low invasive capacity,
induce secretion of human β-defensin 2 (HBD-2), alter the epithelial permeability of differentiated cells and damage
the F-actin cytoskeleton.
Conclusions: These data bring new insights into P. mosselii virulence, since this bacterium has often been
neglected due to its rare occurrence in hospital.
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The genus Pseudomonas is one of the most diverse and
ecologically significant bacterial groups on the planet.
The large size and the plasticity of their genome explain
at least partly their ability to cope with different forms
of stresses (physical, chemical or antimicrobial agents)
resulting in their widespread distribution [1]. The genus
Pseudomonas includes more than 100 species, a number
that is increasing in time [2]. Nearly each year, a new
species is indeed discovered, like P. duriflava, P. batumici
or P. litoralis for example, isolated from a desert soil [3],
the Caucasus Black sea coast [4] or from Mediterranean
seawater [5], respectively. Due to its heterogeneity, the
genus Pseudomonas has undergone numerous taxonomic* Correspondence: nathalie.connil@univ-rouen.fr
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distribution, and reproduction in any mediumchanges depending on the criteria employed for their
definition and delineation: phenotypic, physiologic or
metabolic characteristics, siderotyping, phylogeny based
on 16S rRNA and/or “housekeeping” genes, analysis of
16S-23S rRNA intergenic spacers (ITS) or the use of
functional and ecological genetic markers such as oprF,
oprD or gacA [2,6-8].
P. aeruginosa is by far the most studied species in the
genus Pseudomonas. It is an opportunistic pathogen
that provokes nosocomial infection and causes severe
acute and chronic infections either in healthy or in
immunocompromised individuals [9]. Other Pseudomonas
species have been suspected in human infections [2]. For
example, the very common environmental contaminant P.
fluorescens has also been associated to various clinical
cases [10-14]. This bacterium may particularly colonize
the airways, the urinary tract and blood of immunocom-
promised patients. Recently, some P. fluorescens strainsd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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have a high hemolytic activity and dispose of a complete
type three secretion system arsenal [15-18].
P. mosselii is a novel species, which has been character-
ized in 2002 [19]. It has been linked to P. putida clinical
strains using 16SrDNA, oprF and oprD as markers for
phylogeny-based studies [7,8]. In 2009, McLellan and
Partridge [20] presented a case of prosthetic valve
endocarditis caused by P. mosselii. These authors proposed
that P. mosselii should be regarded as a potential pathogen.
In a previous study, we have found that P. mosselii
strains were able to adhere and to display a necrotic
potential on rat glial cells [21]. To get further insights
into P. mosselii virulence, we investigate in the present
work the cytotoxicity and proinflammatory effects of two
clinical strains of P. mosselii (ATCC BAA-99 and MFY161)
on Caco2/TC7 cells, the transepithelial permeability of
Caco2/TC7 monolayers and the actin network. The
behavior of these bacteria was compared to that of the
well-known opportunistic pathogen P. aeruginosa PAO1.
Results
Cytotoxicity assay
The cytotoxic effect of P. mosselii ATCC BAA-99 and
MFY161 on Caco-2/TC7 cells was determined by
quantification of lactate dehydrogenase (LDH) re-
leased in culture medium (Figure 1). The results
show that P. mosselii ATCC BAA-99 was the less
cytotoxic strain with only 30.1 +/−0.1% of cell lysis
after 24 h of infection. P. mosselii MFY161 exhibited
a cytotoxic activity reaching 64.5 +/−0.1% of lysis
and the cytotoxic activity of P. aeruginosa PAO1 was
higher with 85.6 +/−0.2% of lysis. Enumeration of P.
mosselii ATCC BAA-99 (5 × 108 CFU.mL-1), P. mosselii
MFY161 (4.8 × 108 CFU.mL-1) and P. aeruginosa PAO1
(4.9 × 108 CFU.mL-1), at the end of the infection period





















Figure 1 Cytotoxic effects of P. mosselii ATCC BAA-99, P. mosselii MFY
determined by LDH release assay after 24 h of infection. Results were calcu
*** P < 0.001 versus uninfected Caco-2/TC7 cells, ΔΔΔ P < 0.001 versus P. ae
P. mosselii ATCC BAA-99.Bacterial invasion assay
The capacity of P. mosselii ATCC BAA-99 and MFY161
to enter Caco-2/TC7 cells has been investigated
using the gentamicin exclusion test (Figure 2). The
results show that the two P. mosselii strains studied
can have an invasive behavior with 0.5 +/−0.2 × 105
and 0.2 +/−0.2 × 105 CFU.mL-1 detected intracellularly for
P. mosselii ATCC BAA-99 and MFY161, respectively. The
invasive capacity of P. aeruginosa PAO1 was signifi-
cantly higher with 1.4 +/−0.1 × 105 CFU.mL-1 that
entered Caco-2/TC7 cells.
Quantification of IL-6, IL-8 and HBD-2 secretion
The bacterial proinflammatory effect of P. mosselii ATCC
BAA-99, P. mosselii MFY161 and P. aeruginosa PAO1
was assessed by measuring IL-6 and IL-8 secretion in
Caco-2/TC7 after 24 h of infection. The results show that
the two strains of P. mosselii studied did not induce
significant stimulation of IL-6 (Figure 3A) and IL-8
(Figure 3B) secretion in Caco-2/TC7 compared to unin-
fected cells. On the contrary, the infection of Caco-2/TC7
cells with P. aeruginosa PAO1 led to a major secretion of
IL-8 with 92 +/−13 pg.mL-1 (Figure 3B).
The human β-defensin-2 (HBD-2) was also quantified
in Caco-2/TC7 cells supernatant. The results show that
the two strains of P. mosselii were able to induce HBD-2
secretion by Caco-2/TC7 cells (Figure 3C). Infection with
P. mosselii ATCC BAA-99 and MFY161 strains led to a
major increase of HBD-2 production by Caco-2/TC7 with
125 +/−26 pg.mL-1 and 136 +/−31 pg.mL-1, respectively,
compared to the 4 +/−2 pg.mL-1 basal secretion of HBD-2
in uninfected cells. The induction of HBD-2 by the two
P. mosselii strains was almost similar to that obtained
with P. aeruginosa PAO1 (165 +/−14 pg.mL-1).
Transepithelial electrical resistance measurements
The effect of the bacteria on epithelial permeability was








161 and P. aeruginosa PAO1 on Caco-2/TC7 cells. Cytotoxicity was
lated as the mean values (+/−SEM) of three independent experiments.




































Figure 2 Invasive capacity of P. mosselii ATCC BAA-99, P. mosselii MFY161 and P. aeruginosa PAO1. 4 h after infection of Caco-2/TC7 cells
with the bacteria, extracellular germs were killed by gentamicin. Cells were lysed and the intracellular bacteria were enumerated by plating onto
nutrient agar medium. Results were calculated as the mean values (+/−SEM) of three independent experiments. * P < 0.05 versus P. mosselii ATCC
BAA-99 and P. mosselii MFY161, NS not significant between P. mosselii ATCC BAA-99 and P. mosselii MFY161.
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the onset of the experiment and at times 3, 6, 9 and
24 h. Up to 9 h after the beginning of the experiment,
the TER values of the infected monolayers remained
unchanged (data not shown). After 24 h of infection, the
TER values of the monolayers exposed to the bacteria
were significantly decreased (Figure 4). The decrease of
TER induced by P. mosselii MFY161 was 20.8 +/−4.7%
compared to uninfected control cells whereas P. mosselii
ATCC BAA-99 led to a decrease of TER reaching
39 +/− 3.2% and P. aeruginosa PAO1 provoked a deeper
decrease of the TER value (55.8 +/−5.3%). These falls
in TER cannot be attributed to damages provoked by
acidification of the medium since the pH of the medium
remained constant over the studies.
Actin visualisation
The effect of P. mosselii ATCC BAA-99 and MFY161
on the organization of the sub-membrane F-actin
microfilament network was studied and compared to
that of P. aeruginosa PAO1. Whereas the staining
pattern of untreated Caco-2/TC7 cells showed a continu-
ous fine meshwork of microfilaments lining the cell border
(Figure 5), the cells exposed for 24 h with P. mosselii ATCC
BAA-99, P. mosselii MFY161 or P. aeruginosa PAO1 lost
their normal organization. All these bacteria induced a
dramatic disruption of F-actin.
Discussion
P. mosselii was formally described as a novel species in
2002 through a polyphasic taxonomic approach including
16SrDNA phylogeny, numerical analysis, DNA–DNAhybridization, thermal stability of DNA–DNA hybrids and
siderophore-typing methodology [19]. The several strains
of P. mosselii described to date were isolated in hospital
and some have been suggested as emerging human patho-
gens [19-21]. Our study aimed at investigating the virulence
potential of two of these strains, namely ATCC BAA-99
and MFY161, belonging to the same cluster strongly
related to the hospital-isolated P. putida on the basis of
both oprD or oprF-linked phylogenies [22]. Although
P. putida species is mostly known for its huge capacity
in degradation of numerous carbon sources [23], some
clinical strains have emerged, causing infections in
immunosuppressed hosts and patients with invasive
medical devices. More recently, P. putida has been
involved in war wound infection, and should be con-
sidered as a potential human pathogen, for a review
see Carpenter et al. [24].
In the present study, we further investigated the
cytotoxicity of P. mosselii ATCC BAA-99 and MFY161
strains, and show that they provoked the lysis of the
intestinal epithelial cells Caco-2/TC7, with a major
damage obtained after infection with P. mosselii MFY161.
The cytotoxic levels were lower compared to the
well-known opportunistic pathogen P. aeruginosa PAO1
but almost similar to those observed for P. mosselii
strains on rat glial cells [21], and for the clinical strain
P. fluorescens MFN1032 on Caco-2/TC7 cells [17]. The
gentamicin exclusion test showed that P. mosselii
ATCC BAA-99 and MFY161 can enter Caco-2/TC7
cells. The invasion capacity of the two P. mosselii
strains studied was similar and lower than that of the
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Figure 3 Proinflammatory effects of P. mosselii ATCC BAA-99, P. mosselii MFY161 and P. aeruginosa PAO1 on Caco-2/TC7 cells. IL-6 and
IL-8 cytokines, and HBD-2 were measured in Caco-2/TC7 cells supernatant after 24 h of infection. Results were calculated as the mean values
(+/−SEM) of three independent experiments. *** P < 0.001 versus uninfected Caco-2/TC7 cells, ** P < 0.01 versus uninfected Caco-2/TC7 cells, NS
not significant.
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ATCC BAA-99 and MFY161 was then assessed by meas-
uring the secretion of IL-6 and IL-8 cytokines in Caco-
2/TC7 after 24 h of infection. The results showed that
the two strains did not induce the production of these
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Figure 4 Effects of P. mosselii ATCC BAA-99, P. mosselii MFY161 and P
Caco-2/TC7 cells. Differentiated Caco-2/TC7 cells were infected for 24 h. T
measured across each individual cell monolayer at the onset of the experim
experiments. *** P < 0.001 versus uninfected Caco-2/TC7 cells, ** P < 0.01 vmay serve as a strategy for P. mosselii to escape the im-
mune system. However, P. mosselii ATCC BAA-99 and
MFY161were found to strongly increase the secretion
of HBD-2. Human beta-defensins are known to play a
key role in host defense. In fact, in addition to their
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Figure 5 Effects of P. mosselii ATCC BAA-99, P. mosselii MFY161 and P. aeruginosa PAO1 on the F-actin cytoskeleton of Caco-2/TC7 cells.
Differentiated Caco-2/TC7 cells were infected for 24 h. F-actin was stained and examined using a confocal laser scanning microscope. (A) Uninfected
cells, (B) infection by P. mosselii ATCC BAA-99, (C) infection by P. mosselii MFY161, (D) infection by P. aeruginosa PAO1. Scale bar 100 μm.
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strated to function as multieffector molecules capable of
enhancing host defense by recruiting various innate as
well as adaptive immune cells to the site of infection.
Nevertheless, some pathogens can be resistant to HBD-2
[26] and surprisingly can induce and divert HBD-2
secretion in intestinal epithelial cells to enhance its
capacity of virulence [27].
The effect of P. mosselii ATCC BAA-99 and MFY161 on
epithelial permeability was then evaluated by measuring
the TER across differentiated Caco-2/TC7 monolayers.
The F-actin cytoskeleton was stained with Alexa-488
phalloïdin and examined using a confocal laser scanning
microscope. We observed that the TER of the monolayers
exposed to the bacteria was significantly decreased and
that the F-actin cytoskeleton was completely broken.
Similar results of TER decrease and F-actin disruption
were previously observed with many pathogens including
Salmonella typhimurium, P. aeruginosa and Escherichia
coli [28-30].
Infections caused by multidrug-resistant (MDR) Gram-
negative bacilli have become a growing challenge in
hospital [31]. In a recent study, Giani et al. [32] suggested
that unusual human opportunistic pathogen like P. mosselii
may probably play a role as shuttles for acquiredmetallo-β-lactamases resistance thus an antibiogram was
made for P. mosselii ATCC BAA-99 and MFY161
(see Additional file 1: Table S1). We found that the two
strains were resistant towards 6 of the 16 antibiotics tested
including the ticarcillin beta-lactam, which could support
the above hypothesis.
Conclusion
In conclusion, our study demonstrates that P. mosselii
ATCC BAA-99 and MFY161 are cytotoxic towards
Caco-2/TC7 cells, have low invasive capacity, induce
secretion of human β-defensin 2 (HBD-2), alter the
epithelial permeability of differentiated cells and damage
the F-actin cytoskeleton. These strains are less virulent
than P. aeruginosa PAO1, but their behavior resembles that
of cytotoxic strains of P. fluorescens [17,18] and by thus
may be considered as potential emerging human pathogen.
Methods
Bacterial strains
P. mosselii ATCC BAA-99 is a clinical strain isolated from
tracheal aspirate of a patient suffering from pulmonary
infections [19]. P. mosselii MFY161 was collected from
urine of a patient suffering from alcoholic hepatitis in
Charles Nicolle hospital (Rouen, France), and characterized
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siderotyping [22]. P. aeruginosa PAO1 was obtained from
an international collection. All the strains were routinely
cultivated under vigorous shaking, in ordinary nutrient
broth (Merk, Darmstadt, Germany), at their optimal
growth temperature, 30°C for P. mosselii ATCC BAA-99
and MFY161, 37°C for P. aeruginosa PAO1.
Cell line and culture
Caco-2/TC7 cells were grown in Dulbecco’s Modified
Eagle’s Medium (DMEM, Invitrogen) supplemented
with 15% of heat-inactived fetal calf serum, 2 mM of
L-glutamine, 100 U.mL-1 each of penicillin and strepto-
mycin and 1% of non-essential amino acids. For the ex-
perimental assays, the cells were seeded at a density of 105
cells.cm-2 in 24-wells tissue culture plates, or on inserts
(6.4 mm diameter, 3 μm pore size, Falcon) to obtain fully
differentiated cells. The cells were cultured at 37°C in
5% CO2-95% air atmosphere and the medium was
changed daily.
Cell infection
Bacteria of overnight culture were harvested by centrifu-
gation (5000 g, 5 min, 20°C) and resuspended at a density
of 108 colony forming unit (CFU).mL-1 in cell culture
medium without serum and antibiotics. Caco-2/TC7 cells
grown on 24-wells culture plates or inserts were washed
twice with fresh culture medium and the bacterial suspen-
sions were applied to the cell surface at a concentration of
108 CFU.cm-2, resulting to a multiplicity of infection
(MOI) of 100. Infected cells were then incubated at 37°C
in 5% CO2-95% air during 24 h for all experiments,
excepted 4 h of infection for the invasion test. Each assay
was conducted in triplicate in independent experiments
(successive passages of Caco-2/TC7 cells).
Cytotoxicity assay
Cytotoxicity assay was performed on confluent Caco-2/TC7
grown in 24-wells culture plates. After 24 h of infection,
the supernatants from Caco-2/TC7 monolayers were
collected and the concentration of lactate dehydrogenase
(LDH), a cytoplasmic enzyme released upon cell death,
was determined using an enzymatic assay (Cytotox 96
Promega, Charbonnieres, France) as previously described
[17]. Caco-2/TC7 cells exposed to Triton ×100 (0.9%) were
used as a control of total LDH release (100% dead cells).
Bacterial invasion assay
After 4 h of infection, Caco-2/TC7 monolayers were
washed with phosphate-buffered saline (PBS). Adherent
bacteria were killed by incubation for 1 h with 300 μg.mL-1
gentamycin, an antibiotic that does not cross the
cytoplasmic membrane of eukaryotic cells and then only
kills bacteria not internalized in cells. Caco-2/TC7monolayers were washed 3 times with PBS to remove the
antibiotic and dead bacteria. The cells were then lysed by
incubation for 15 min with 0.5% Triton ×100 to release
the intracellular bacteria and the lysates were plated onto
nutrient agar to determine the number of internalized
bacteria.
Quantification of IL-6, IL-8 and HBD-2
After 24 h of infection with the bacterial suspensions,
the levels of IL-6 and IL-8 cytokines were measured in
Caco-2/TC7 cells supernatant using ELISA Quantikine
kits (R&D systems). The human β-defensin-2 (HBD-2)
was quantified using the Defensin 2, beta (Human) -
ELISA Kit (Phoenix Pharmaceuticals inc). These assays
were conducted according to the manufacturer’s protocols.
Transepithelial electrical resistance measurements
Caco-2/TC7 cells grown on inserts were used at
21 days post-confluence (fully differentiated cells) and
the transepithelial electrical resistance (TER) of the
monolayers infected or not with the bacterial strains
was measured during 24 h using the Millicell Electrical
Resistance System (Millipore Corp, Bedford, MA). TER
values are expressed as percentages of the pre-infection
level of the TER (baseline) measured for each individual
cell monolayer in the inserts.
Actin visualisation
Fully differentiated Caco-2/TC7 monolayers were exposed
to the bacterial strains for 24 h. At the end of the experi-
ment, the cells were washed with PBS, fixed for 10 min in
3.7% paraformaldehyde and permeabilized for 5 min with
0.1% Triton ×100 at room temperature. The cells were
then incubated with 1% bovine serum albumin in PBS for
10 min and the apical F-actin cytoskeleton was stained
with Alexa-488 phalloïdin (1U/insert) for 45 min at room
temperature. Following three washes in PBS, cell mono-
layers were examined using a confocal laser scanning
microscope (Zeiss, LSM710).
Statistical analysis
All experiments were conducted independently at least
three times. The results are expressed as means +/−
SEM and statistical significance were performed by
Student’s t-test.
Additional file
Additional file 1: Table S1. Antibiotic susceptibility pattern of P. mosselii
ATCC BAA-99 and P. mosselii MFY161. The antibiotics tested were ticarcillin
(TIC), piperacillin (PRL),colistin (CT), imipenem (IPM), aztreonam (ATM),
tobramycin (TOB), gentamycin (GN), amikacin (AK), ticarcillin + clavulanic
acid (TIM), ceftazidime (CAZ), ciprofloxacin (CIP), cefsulodin (CFS),
levofloxacin (LEV), trimethoprim-sulphamethoxazole (SXT), fosfomycin (FF)
and netilmicine (NET). R, resistant; I, intermediate; S, susceptible.
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